Articles

IGM Biosciences Inc.’s stock tumbled 14% Tuesday, as analysts weighed in with dismay on the company’s pivot away from oncology to a focus on autoimmune diseases, with at least two opting to lower their ratings.

PepsiCo’s stock rose Tuesday, bucking the selloff in the broader stock market, after the beverage and snacks giant announced an agreement to buy Mexican-American foods maker Siete Foods for $1.2 billion a week before earnings are released.

Crypto bulls have expected the potential approval of options on bitcoin ETFs to allow institutional investors to execute more strategies, including some that may lead to bitcoin’s price much higher.

Company sales rise 10%, beating analyst estimates

A Barclays analyst says the December quarter “looks to be increasingly at risk” as iPhone demand could disappoint.

Cannabis is playing a bigger role in the U.S. presidential race than in any past campaign, with Vice President Kamala Harris reaffirming support for legalization this week.

MarketWatch digs into what the Trump-Vance ticket and the Harris-Walz ticket are promising for the electric-vehicle industry and car buyers.

Construction spending fell 0.1% in August, the Commerce Department reported Tuesday.

U.S. job openings rose toward the end of summer for the first time in three months, but people looking for work are having a harder time getting a job since fewer companies are hiring.

McCormick’s stock edged higher Tuesday, after the spices and flavor company beat fiscal third-quarter profit expectations and raised its full-year outlook, as volume increased for the first time in about three years.

ISM PMI holds steady at 47.2% in September, below forecast 47.5%

An extended strike could mean higher logistical and supply-chain costs — as well as potential product shortages — for some big names in retail, according to Truist.